Journal article

Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

Christopher A Maxwell, Javier Benitez, Laia Gomez-Baldo, Ana Osorio, Nuria Bonifaci, Ricardo Fernandez-Ramires, Sylvain V Costes, Elisabet Guino, Helen Chen, Gareth JR Evans, Pooja Mohan, Isabel Catala, Anna Petit, Helena Aguilar, Alberto Villanueva, Alvaro Aytes, Jordi Serra-Musach, Gad Rennert, Flavio Lejbkowicz, Paolo Peterlongo Show all

PLoS Biology | PUBLIC LIBRARY SCIENCE | Published : 2011

University of Melbourne Researchers

Grants

Awarded by Spanish Ministries of Health, and Science ane Innovation


Awarded by FIS


Awarded by RTICCC


Awarded by Spanish Association Against Cancer


Awarded by AGAUR Catalan Government Agency


Awarded by Michael Cuccione Foundation for Childhood Cancer Research, Cancer Research-UK


Awarded by Association for International Cancer Research


Awarded by Dutch Cancer Society


Awarded by Associazione Italiana per la Ricerca sul Cancro


Awarded by Italian Ministero della Salute


Awarded by Italian Ministero dell'Universita e Ricerca


Awarded by Fondazione IRCCS Istituto Nazionale Tumori


Awarded by Australian National Health and Medical Research Council


Awarded by German Cancer Aid


Awarded by Center for Molecular Medicine Cologne


Awarded by National Cancer Institute (USA)


Awarded by National Institutes of Health


Awarded by Research Triangle Institute Informatics Support Center


Awarded by Specialized Program of Research Excellence (SPORE)


Awarded by Department of Defense


Awarded by Academy of Finland


Awarded by EU


Awarded by Cancer Research UK


Funding Acknowledgements

This work was funded by the Spanish Ministries of Health, and Science ane Innovation (CB07/02/2005; FIS 08/1120, 08/1359, 08/1635, and 09/02483; RTICCC RD06/0020/1060 and RD06/0020/0028; Transversal Action Against Cancer; the Spanish Biomedical Research Centre Networks for Epidemiology and Public Health, and Rare Diseases; and the "Ramon y Cajal" Young Investigator Program), the Spanish National Society of Medical Oncology (2010), the Spanish Association Against Cancer (AECC 2010), the AGAUR Catalan Government Agency (2009SGR1489 and 2009SGR293; and the Beatriu Pinos Postdoctoral Program), the Ramon Areces Foundation (XV), the "Roses Contra el Cancer" Foundation, the Michael Cuccione Foundation for Childhood Cancer Research, Cancer Research-UK (C490/A10119, C1287/A8874, C1287/A10118, C5047/A8385, and C8197/A10123), the National Institute for Health Research (UK), the Association for International Cancer Research (AICR-07-0454), the Ligue National Contre le Cancer (France), the Association "Le cancer du sein, parlons-en!", the Dutch Cancer Society (NKI 1998-1854, 2004-3088, and 2007-3756), the Fondazione Italiana per la Ricerca sul Cancro ("Hereditary Tumors"), the Associazione Italiana per la Ricerca sul Cancro (4017), the Italian Ministero della Salute (RFPS-2006-3-340203 and "Progetto Tumori Femminili"), the Italian Ministero dell'Universita e Ricerca (RBLAO3-BETH), the Fondazione IRCCS Istituto Nazionale Tumori (INT "5x1000"), the Fondazione Cassa di Risparmio di Pisa (Istituto Toscano Tumori), the National Breast Cancer Foundation (Australia), the Australian National Health and Medical Research Council (145684, 288704, and 454508), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, the Cancer Foundation of Western Australia, the German Cancer Aid (107054), the Center for Molecular Medicine Cologne (TV93), the National Cancer Institute (USA; CA128978 and CA122340), National Institutes of Health (RFA-CA-06-503, BCFR U01 CA69398, CA69417, CA69446, CA69467, CA69631, and CA69638), the Research Triangle Institute Informatics Support Center (RFP N02PC45022-46), the Specialized Program of Research Excellence (SPORE P50 CA83638 and CA113916), the Department of Defense Breast Cancer Research Program (05/0612), the Eileen Stein Jacoby Fund, the Breast Cancer Research Foundation, the Marianne and Robert MacDonald Foundation, the Komen Foundation, the Helsinki University Central Hospital Research Fund, the Academy of Finland (110663), the Finnish Cancer Society, the Sigrid Juselius Foundation, and the EU FP7 (223175, HEALTH-F2-2009-223175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.